Judith Berastegui‐Cabrera

Statistics

Publications

Citations

406

H-Index

Active since

2019

Affiliations

Instituto de Biomedicina de Sevilla(Current)

Universidad de Sevilla

Hospital Universitario Virgen del Rocío

The University of Texas Medical Branch at Galveston

University of Calabria

Judith Berastegui‐Cabrera is an author at Instituto de Biomedicina de Sevilla specializing in antiviral therapy, virology, and antiviral pharmacology.

ORCID

Publications per year

2019–2022

Publications

Dendritic cell deficiencies persist seven months after SARS-CoV-2 infection

Alberto Pérez‐Gómez, Joana Vitallé, Carmen Gasca‐Capote et al. · Cellular and Molecular Immunology · 2021 · 127 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Excretion and viability of SARS-CoV-2 in feces and its association with the clinical outcome of COVID-19

Cristina Cerrada-Romero, Judith Berastegui‐Cabrera, Pedro Camacho‐Martínez et al. · Scientific Reports · 2022 · 61 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +15

Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections

José Antonio Marrugal‐Lorenzo, Ana Serna‐Gallego, Judith Berastegui‐Cabrera et al. · Scientific Reports · 2019 · 58 citations · Full text

Medicine, Infectious Diseases, Pharmacology +16

SARS-CoV-2 viral load in nasopharyngeal swabs is not an independent predictor of unfavorable outcome

Sonsoles Salto‐Alejandre, Judith Berastegui‐Cabrera, Pedro Camacho‐Martínez et al. · Scientific Reports · 2021 · 33 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +14

Structure–Activity Relationship Studies on Diversified Salicylamide Derivatives as Potent Inhibitors of Human Adenovirus Infection

Jimin Xu, Judith Berastegui‐Cabrera, Haiying Chen et al. · Journal of Medicinal Chemistry · 2020 · 29 citations

Pharmacy, Medicinal Chemistry, Pharmacology +16

1–5 of 11